These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29119633)

  • 41. Anti-astrocyte autoantibodies in Guillain-Barre Syndrome--possible involvement in the pathophysiology of a psychosyndrome?
    Görtzen A; Schlüter S; Veh RW
    Autoimmunity; 2004; 37(6-7):521-8. PubMed ID: 15621580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
    Eldar AH; Chapman J
    Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guillain-Barré syndrome.
    Kountouras J; Deretzi G; Grigoriadis N; Zavos C; Boziki M; Gavalas E; Katsinelos P; Tzilves D; Giouleme O; Lazaraki G
    Lancet Neurol; 2008 Dec; 7(12):1080-1; author reply 1083-5. PubMed ID: 19007730
    [No Abstract]   [Full Text] [Related]  

  • 44. [Molecular Mimicry and Guillain-Barré Syndrome].
    Yuki N
    Brain Nerve; 2015 Nov; 67(11):1341-6. PubMed ID: 26560949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
    Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
    Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Guillain-Barré syndrome associated with CASPR2 antibodies: two paediatric cases.
    Rosch RE; Bamford A; Hacohen Y; Wraige E; Vincent A; Mewasingh L; Lim M
    J Peripher Nerv Syst; 2014 Sep; 19(3):246-9. PubMed ID: 25413786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased plasmacytoid dendritic cells in Guillain-Barré syndrome.
    Wang YZ; Feng XG; Wang Q; Xing CY; Shi QG; Kong QX; Cheng PP; Zhang Y; Hao YL; Yuki N
    J Neuroimmunol; 2015 Jun; 283():1-6. PubMed ID: 26004148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy.
    Willison HJ
    J Peripher Nerv Syst; 2012 Dec; 17 Suppl 3():3-8. PubMed ID: 23279424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-GM1 IgG antibodies in Guillain-Barré syndrome: fine specificity is associated with disease severity.
    Lardone RD; Yuki N; Odaka M; Daniotti JL; Irazoqui FJ; Nores GA
    J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):629-33. PubMed ID: 19965859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
    Yuki N
    Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome.
    Schwerer B
    Microbes Infect; 2002 Mar; 4(3):373-84. PubMed ID: 11909748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Acute motor axon neuropathy, subtype of Guillain-Barre syndrome].
    Lefèvre C; Martinez L; Abdulnayef A; De Broucker T
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):616-8. PubMed ID: 12072835
    [No Abstract]   [Full Text] [Related]  

  • 54. Haemophilus influenzae infection and Guillain-Barré syndrome.
    Mori M; Kuwabara S; Miyake M; Noda M; Kuroki H; Kanno H; Ogawara K; Hattori T
    Brain; 2000 Oct; 123 ( Pt 10)():2171-8. PubMed ID: 11004133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Visual Detection of Human Antibodies Using Sugar Chain-Immobilized Fluorescent Nanoparticles: Application as a Point of Care Diagnostic Tool for Guillain-Barré Syndrome.
    Shinchi H; Yuki N; Ishida H; Hirata K; Wakao M; Suda Y
    PLoS One; 2015; 10(9):e0137966. PubMed ID: 26378448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The first total synthesis of ganglioside GalNAc-GD1a, a target molecule for autoantibodies in Guillain-Barré syndrome.
    Fujikawa K; Nakashima S; Konishi M; Fuse T; Komura N; Ando T; Ando H; Yuki N; Ishida H; Kiso M
    Chemistry; 2011 May; 17(20):5641-51. PubMed ID: 21469228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
    Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
    J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Etiology and pathogeneses of Guillain-Barré syndrome and related diseases: focusing on anti-gangliosides antibody].
    Uchibori A; Chiba A
    No To Shinkei; 2005 Feb; 57(2):97-106. PubMed ID: 15856755
    [No Abstract]   [Full Text] [Related]  

  • 60. [A case of Guillain-Barré syndrome complicated with severe autonomic failure and presented elevated anti-GD1b and anti-GQ1b antibody].
    Inoue K; Kohriyama T; Ikeda J; Maruyama H; Nakamura S
    Rinsho Shinkeigaku; 2002 Jan; 42(1):13-7. PubMed ID: 12355845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.